Introduction: Neglected tropical diseases are a group of communicable diseases that occur in tropical and subtropical conditions and are closely related to poverty and inadequate sanitation conditions. Among these entities, chikungunya remains one of the most widely spread diseases. Although the main symptoms are related to a febrile syndrome, cardiovascular (CV) involvement has been reported, with short- and long-term implications. As part of the “Neglected Tropical Diseases and other Infectious Diseases involving the Heart” (NET-Heart) Project, the aim of this review is to compile all the information available regarding CV involvement of this disease, to help healthcare providers gain knowledge in this field, and contribute to improving early diagnosis, treatment, and prevention strategies. Methods: We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement in conducting and reporting this systematic review. The search was conducted using MEDLINE/PubMed, SciELO, and LILACS databases to identify any relevant studies or reviews detailing an association between chikungunya and cardiac involvement published from January 1972 to May 31, 2020. Results: Despite its mechanism not being fully understood, CV involvement has been described as the most frequent atypical presentation of chikungunya (54.2%). Myocarditis is the most prevalent CV complication. Different rhythm disturbances have been reported in 52% of cases, whereas heart failure was reported in 15% of cases, pericarditis in 5%, and acute myocardial infarction in 2%. Overall estimated CV mortality is 10%, although in patients with other comorbidities, it may increase up to 20%. In the proper clinical setting, the presence of fever, polyarthralgia, and new-onset arrhythmia suggests chikungunya virus-related myocarditis. Conclusion: Although most cases are rarely fatal, CV involvement in chikungunya infection remains the most frequent atypical presentation of this disease and may have severe manifestations. Timely diagnosis and appropriate management are necessary to improve patient outcomes.

1.
Burt
FJ
,
Rolph
MS
,
Rulli
NE
,
Mahalingam
S
,
Heise
MT
.
Chikungunya: a re-emerging virus
.
Lancet
.
2012
;
379
(
9816
):
662
71
. .
2.
Alvarez
MF
,
Bolívar-Mejía
A
,
Rodriguez-Morales
AJ
,
Ramirez-Vallejo
E
.
Cardiovascular involvement manifestations of systemic Chikungunya virus infection: a systematic review
.
F1000Res
.
2017
;
6
:
390
.
3.
Thiberville
SD
,
Moyen
N
,
Dupuis-Maguiraga
L
,
Nougairede
A
,
Gould
EA
,
Roques
P
, et al.
Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy
.
Antiviral Res
.
2013
;
99
(
3
):
345
70
. .
4.
Burt
FJ
,
Chen
W
,
Miner
JJ
,
Lenschow
DJ
,
Merits
A
,
Schnettler
E
, et al.
Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen
.
Lancet Infect Dis
.
2017
;
17
(
4
):
e107
17
. .
5.
Badawi
A
,
Ryoo
SG
,
Vasileva
D
,
Yaghoubi
S
.
Prevalence of chronic comorbidities in chikungunya: a systematic review and meta-analysis
.
Int J Infect Dis
.
2018
;
67
:
107
13
. .
6.
Burgos
LM
,
Farina
J
,
Liendro
MC
,
Saldarriaga
C
,
Liprandi
AS
,
Wyss
F
, et al.
Neglected tropical diseases and other infectious diseases affecting the heart. The NET-heart project: rationale and design
.
Glob Heart
.
2020
;
15
(
1
):
60
. .
7.
Moher
D
,
Liberati
A
,
Tetzlaff
J
,
Altman
DG
.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
.
J Clin Epidemiol
.
2009
;
62
:
1006
12
.
8.
National Heart, Lung and Blood Institute
.
Study quality assessment tools
. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
9.
Silva
LA
,
Dermody
TS
.
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies
.
J Clin Invest
.
2017
;
127
(
3
):
737
49
. .
10.
Obeyesekere
I
,
Hermon
Y
.
Myocarditis and cardiomyopathy after arbovirus infections (dengue and Chikungunya fever)
.
Br Heart J
.
I972
;
34
(
8
):
821
7
.
11.
Mendoza
I
,
Morr
I
,
Mendoza
I
,
Morr
Ca
,
Morr
Cl
,
Meza
Y
, et al.
Chikungunya myocarditis: an emerging threat to América
.
J Am Coll Cardiol
.
2015
;
65
(
10
):
A946
.
12.
Villamil-Gómez
WE
,
Ramirez-Vallejo
E
,
Cardona-Ospina
JA
,
Silvera
LA
,
Rodríguez-Morales
AJ
.
Electrocardiographic alterations in patients with chikungunya fever from Sucre, Colombia: a 42-case series
.
Travel Med Infect Dis
.
2016
;
14
(
5
):
510
2
.
13.
Jain
M
,
Rai
S
,
Chakravarti
A
.
Chikungunya: a review
.
Trop Doct
.
2008
;
38
(
2
):
70
2
. .
14.
Carrera
J
,
Díaz
Y
,
Denis
B
,
Barahona de Mosca
I
,
Rodriguez
D
,
Cedeño
I
, et al.
Unusual pattern of Chikungunya virus epidemic in the Americas, the Panamanian experience
.
PLoS Negl Trop Dis
.
2017
;
11
(
2
):
1
23
.
15.
Bodenmann
P
,
Genton
B
.
Chikungunya: an epidemic in real time
.
Lancet
.
2006
;
368
(
9531
):
258
. .
16.
Harapan
H
,
Michie
A
,
Mudatsir
M
,
Nusa
R
,
Yohan
B
,
Wagner
AL
, et al.
Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis
.
BMC Infect Dis
.
2019
;
19
(
1
):
243
. .
17.
Simon
F
,
Paule
P
,
Oliver
M
.
Case report: Chikungunya virus–induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics?
Am J Trop Med Hyg
.
2008
;
78
(
2
):
212
3
.
18.
Farias
LABG
,
Beserra
FLCN
,
Fernandes
L
,
Teixeira
AAR
,
Ferragut
JM
,
Girão
ES
, et al.
Myocarditis following recent chikungunya and dengue virus coinfection: a case report
.
Arq Bras Cardiol
.
2019
;
113
(
4
):
783
6
. .
19.
Mirabel
M
,
Vignaux
O
,
Lebon
P
,
Legmann
P
,
Weber
S
,
Meune
C
.
Acute myocarditis due to Chikungunya virus assessed by contrast-enhanced MRI
.
Int J Cardiol
.
2007
;
121
(
1
):
e7
8
.
20.
Kularatne
SA
,
Pathirage
MM
,
Kumarasiri
PV
,
Gunasena
S
,
Mahindawanse
SI
.
Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005
.
Trans R Soc Trop Med Hyg
.
2007
;
101
(
8
):
804
8
. .
21.
Torres
JR
,
Leopoldo Códova
G
,
Castro
JS
,
Rodríguez
L
,
Saravia
V
,
Arvelaez
J
, et al.
Chikungunya fever: atypical and lethal cases in the Western hemisphere: a Venezuelan experience
.
ID Cases
.
2014 Dec 18
;
2
(
1
):
6
10
.
22.
Wenxi
A
,
Ningning
G
,
YilinC
,
Jin
S
,
Xia
J
.
Recent progress on Chikungunya virus research
.
Virol Sin
.
2017
;
32
(
6
):
441
53
.
23.
Gonzalez Carta
KA
,
Mendoza-Britto
IJ
,
Finizola
V
,
Morr
I
,
Torres
I
,
Meza
Y
, et al.
Bradycardia as a manifestation of chikungunya myocarditis. A new threat to America
.
Circulation
.
2016
;
134
:
13292
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.